Atlas Trials

A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722

Clinical trial NCT02346890 · COMPLETED

Trial details

NCT number
NCT02346890
Sponsor
Ardelyx
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2013-04-01
Primary completion
2013-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.